
Bo Zhang
Articles
-
3 weeks ago |
dx.doi.org | Haoxiang Zhang |Huimin Dong |Ye E Wu |Bo Zhang
-
3 weeks ago |
pubs.acs.org | Haoxiang Zhang |Huimin Dong |Ye E Wu |Bo Zhang
Organic LettersCite this: Org. Lett. 2025, XXXX, XXXClick to copy citationCitation copied!Learn about these metricsArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days. Citations are the number of other articles citing this article, calculated by Crossref and updated daily.
-
Jan 16, 2025 |
nature.com | Bo Zhang |Shiyu Chen |Nadine Rouphael |Angela R. Branche |David J. Diemert |Daniel S. Graciaa | +15 more
AbstractNeutralizing antibody titer has been a surrogate endpoint for guiding COVID-19 vaccine approval and use, although the pandemic’s evolution and the introduction of variant-adapted vaccine boosters raise questions as to this surrogate’s contemporary performance.
-
Jan 14, 2025 |
mdpi.com | Lu Wang |Bo Zhang
1. IntroductionAt present, global energy development is facing profound changes. The trends of cleaner fossil energy, cleaner energy scale, multi-energy complementary synthesis, and end-use energy intelligence accelerate the evolution of the energy technology revolution, and industrial change has become the world’s most active field of innovation [].
-
Jan 12, 2025 |
pubs.acs.org | Guopeng Lin |Bo Zhang |Zhihao Qu |Min Guo
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →